Melanoma and Skin Cancer Trials is governed by a volunteer Board of Directors, comprising representatives of specialist disciplines from leading melanoma and skin cancer institutions across Australia and New Zealand, as well as members from the lay community.
Our Scientific Advisory Board is supported by Discipline-Specific Advisories to facilitate robust scientific review of new trial proposals and supervision of ongoing research.
Our Discipline-Specific Advisories comprise over 240 specialists and researchers, who work together to develop and plan new trials, receive updates on trials in process, and discuss new directions in melanoma medicine in order to improve the lives of patients.
